UK's Inspiration Healthcare H1 revenue falls on absence of prior-year export contracts
UK's Inspiration Healthcare H1 revenue falls on absence of prior-year export contracts
Overview
UK neonatal intensive care device maker's half-year revenue fell due to prior period one-off contracts
SLE product revenues grew 38% yr/yr excluding one-off export contracts
Outlook
Inspiration Healthcare expects to close the financial year slightly ahead of company-compiled market expectations
Company enters second half with confidence and a strong orderbook
Result Drivers
SLE PRODUCT GROWTH - SLE product revenues rose 38% yr/yr excluding prior period one-off export contracts, reflecting continued demand for core neonatal intensive care products
AIRION SALES - Airon revenues increased by 40% to £1.6 mln, driven by an initial order under a three-year purchasing agreement with a large US healthcare provider
MEDTECH DISTRIBUTION - MedTech distribution revenues grew 7% yr/yr, contributing to overall revenue growth
Company press release: ID:nRSH7545Ta
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| GBP 22 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Inspiration Healthcare Group PLC is GBp44.00, about 137.8% above its September 7 closing price of GBp18.50
Reuters Recommended Reads
Sept 7 - UK's IQE swings to first-half profit and sees more AI data centre upside
Sept 7 - UK's Standard Life first-half profit beats on strong pension-risk transfers market
Sept 7 - UK's Standard Life H1 operating profit rises 25%
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)